Patents by Inventor Kyle Bradley Pascual Clagg
Kyle Bradley Pascual Clagg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250074893Abstract: Provided herein are methods of synthesizing quinazoline compounds comprising at least one atropisomeric center.Type: ApplicationFiled: November 13, 2024Publication date: March 6, 2025Applicants: Genentech, Inc., Hoffmann-La Roche Inc.Inventors: NGIAP-KIE LIM, JEFF SHEN, LAUREN ELIZABETH SIROIS, JACOB C. TIMMERMAN, ETIENNE TRACHSEL, NICHOLAS ANDREW WHITE, JIE XU, HAIMING ZHANG, STEPHAN BACHMANN, RAPHAEL BIGLER, KYLE BRADLEY PASCUAL CLAGG, ANTONIO GIOVANNI DIPASQUALE, FRANCIS GOSSELIN, UGO JONATHAN ORCEL, ROLAND CHRISTOPH MEIER
-
Publication number: 20250059155Abstract: Provided herein are methods to synthesize compounds useful in the treatment of cancer where such compounds comprise a quinazolinyl core moiety and at least one stereoisomeric or atropisomeric moiety.Type: ApplicationFiled: July 18, 2024Publication date: February 20, 2025Applicants: Genentech, Inc., Hoffmann-La Roche Inc.Inventors: Rene LEBL, Ngiap Kie LIM, Roland Christoph MEIER, Ugo Jonathan ORCEL, Joerg SEDELMEIER, Jeff SHEN, Lauren Elizabeth SIROIS, Jacob C. TIMMERMAN, Etienne TRACHSEL, Nicholas Andrew WHITE, Jie XU, Haiming ZHANG, Stephan BACHMANN, Thomas Michael BASS, Raphael BIGLER, Johannes Adrian BURKHARD, Kyle Bradley Pascual CLAGG, Francis GOSSELIN, Chong HAN, Dainis KALDRE, Sean M. KELLY, Sebastian HEROLD, Christian LEITNER
-
Patent number: 12172982Abstract: Provided herein are methods of synthesizing quinazoline compounds comprising at least one atropisomeric center.Type: GrantFiled: August 10, 2021Date of Patent: December 24, 2024Assignees: Genentech, Inc., Hoffmann-La Roche Inc.Inventors: Ngiap-Kie Lim, Jeff Shen, Lauren Elizabeth Sirois, Jacob C. Timmerman, Etienne Trachsel, Nicholas Andrew White, Jie Xu, Haiming Zhang, Stephan Bachmann, Raphael Bigler, Kyle Bradley Pascual Clagg, Antonio Giovanni Dipasquale, Francis Gosselin, Ugo Jonathan Orcel, Roland Christoph Meier
-
Patent number: 12071422Abstract: Provided herein are methods to synthesize compounds useful in the treatment of cancer where such compounds comprise a quinazolinyl core moiety and at least one stereoisomeric or atropisomeric moiety.Type: GrantFiled: February 3, 2023Date of Patent: August 27, 2024Assignees: Genentech, Inc., Hoffmann-La Roche Inc.Inventors: Rene Lebl, Ngiap Kie Lim, Roland Christoph Meier, Ugo Jonathan Orcel, Joerg Sedelmeier, Jeff Shen, Lauren Elizabeth Sirois, Jacob C. Timmerman, Etienne Trachsel, Nicholas Andrew White, Jie Xu, Haiming Zhang, Stephan Bachmann, Thomas Michael Bass, Raphael Bigler, Johannes Adrian Burkhard, Kyle Bradley Pascual Clagg, Francis Gosselin, Chong Han, Dainis Kaldre, Sean M. Kelly, Sebastian Herold, Christian Leitner
-
Publication number: 20230250074Abstract: Provided herein are methods to synthesize compounds useful in the treatment of cancer where such compounds comprise a quinazolinyl core moiety and at least one stereoisomeric or atropisomeric moiety.Type: ApplicationFiled: February 3, 2023Publication date: August 10, 2023Applicants: Genentech, Inc., Hoffmann-La Roche Inc.Inventors: Rene LEBL, Ngiap Kie LIM, Roland Christoph MEIER, Ugo Jonathan ORCEL, Joerg SEDELMEIER, Jeff SHEN, Lauren Elizabeth SIROIS, Jacob C. TIMMERMAN, Etienne TRACHSEL, Nicholas Andrew WHITE, Jie XU, Haiming ZHANG, Stephan BACHMANN, Thomas Michael BASS, Raphael BIGLER, Johannes Adrian BURKHARD, Kyle Bradley Pascual CLAGG, Francis GOSSELIN, Chong HAN, Dainis KALDRE, Sean M. KELLY, Sebastian HEROLD, Christian LEITNER
-
Patent number: 11325912Abstract: A method of regio-selectively synthesizing an imidazo-pyrimidine compound of formulae (XXa) or (XXb) comprising a step of coupling a first compound of formula XX-P1a or XX-P1b with a second compound of formula XX-P2 This annulation reaction between ?-ethoxy acrylamides and phosphorylated aminoimidazoles to furnish imidazo[1,2-a]pyrimidin-amines relies on steering effects from endocyclic and exocyclic phosphorylated aminoimidazoles. The reaction furnishes either 2-amino or 4-amino constitutional isomers of imidazo[1,2-a]pyrimidines with good yields and ranges of 90:10-99:1 regio-selectivity. The reaction is useful in the synthesis of various tracer molecules used in the study of neurological conditions such as where R3 and R4 together with the imidazole ring atoms to which they are bonded form a phenyl ring and the products are substituted benzimidazopyrimidines.Type: GrantFiled: May 7, 2020Date of Patent: May 10, 2022Assignee: Genentech, Inc.Inventors: Kyle Bradley Pascual Clagg, Nicholas Andrew White, Haiming Zhang, Francis Gosselin, William Nack, Paul D. O'Shea
-
Publication number: 20220081413Abstract: Provided herein are methods of synthesizing quinazoline compounds comprising at least one atropisomeric center.Type: ApplicationFiled: August 10, 2021Publication date: March 17, 2022Applicants: Genentech, Inc., Hoffmann-La Roche Inc.Inventors: Ngiap-Kie Lim, Jeff Shen, Lauren E. Sirois, Jacob C. Timmerman, Etienne Trachsel, Nicholas A. White, Jie Xu, Haiming Zhang, Stephan Bachmann, Raphael Bigler, Kyle Bradley Pascual Clagg, Antonio Dipasquale, Francis Gosselin, Ugo Jonathan Orcel, Roland Christoph Meier
-
Patent number: 11136330Abstract: A method of synthesizing comprising a step of making an imidazo-pyrimidine compound by coupling a first compound of formula (II) with a second compound of formula (III) Followed by a deprotection and tosylation step. The methods are able to produce an isotopically substituted molecule having upwards of 95% purity relative to non-isotopically substituted molecules.Type: GrantFiled: May 7, 2020Date of Patent: October 5, 2021Assignee: Genentech, Inc.Inventors: Kyle Bradley Pascual Clagg, Nicholas Andrew White, Haiming Zhang, Francis Gosselin, William Nack, Paul D. O'Shea
-
Publication number: 20200369670Abstract: A method of regio-selectively synthesizing an imidazo-pyrimidine compound of formulae (XXa) or (XXb) comprising a step of coupling a first compound of formula XX-P1a or XX-P1b with a second compound of formula XX-P2 This annulation reaction between ?-ethoxy acrylamides and phosphorylated aminoimidazoles to furnish imidazo[1,2-a]pyrimidin-amines relies on steering effects from endocyclic and exocyclic phosphorylated aminoimidazoles. The reaction furnishes either 2-amino or 4-amino constitutional isomers of imidazo[1,2-a]pyrimidines with good yields and ranges of 90:10-99:1 regio-selectivity. The reaction is useful in the synthesis of various tracer molecules used in the study of neurological conditions such as where R3 and R4 together with the imidazole ring atoms to which they are bonded form a phenyl ring and the products are substituted benzimidazopyrimidines.Type: ApplicationFiled: May 7, 2020Publication date: November 26, 2020Applicant: Genentech, Inc.Inventors: Kyle Bradley Pascual Clagg, Nicholas Andrew White, Haiming Zhang, Francis Gosselin, William Nack, Paul D. O'Shea
-
Publication number: 20200354369Abstract: A method of synthesizing comprising a step of making an imidazo-pyrimidine compound by coupling a first compound of formula (II) with a second compound of formula (III) Followed by a deprotection and tosylation step. The methods are able to produce an isotopically substituted molecule having upwards of 95% purity relative to non-isotopically substituted molecules.Type: ApplicationFiled: May 7, 2020Publication date: November 12, 2020Applicant: Genentech, Inc.Inventors: Kyle Bradley Pascual Clagg, Nicholas Andrew White, Haiming Zhang, Francis Gosselin, William Nack, Paul D. O'Shea